Clinical trial
Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease…
NCT00348283 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00348283 |
|---|---|
| Title | Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Involving the Colon |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab Endoscopy Trial to Evaluate the Effects on Mucosal Healing in Subjects With Crohn's Disease Involving the Colon |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Biological |
| Interventions | adalimumab, placebo |
| Enrollment | 135 |
| Start date | Aug 1, 2006 |
| Primary completion | Sep 1, 2008 |
| First posted | Jul 4, 2006 |
| Last update posted | Apr 11, 2011 |
| Countries | Austria, Belgium, Canada, France, Germany, Italy, Netherlands, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: